Gluteal tendinitis

M13_GLUTEALTEND

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 M76.0
  • Cause of death: ICD-10 M76.0

2 out of 7 registries used, show all original rules.

1391

4. Check minimum number of events

None

1391

5. Include endpoints

None

1391

6. Filter based on genotype QC (FinnGen only)

1391

Control definitions (FinnGen only)

Control exclude
M13_DORSOPATHY

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
M76
Name in latin
Tendinitis musculi glutei

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 5539 4224 1289
Only index persons 5456 4184 1272
Unadjusted period prevalence (%)
Whole population 0.10 0.12 0.04
Only index persons 0.13 0.15 0.05
Median age at first event (years)
Whole population 56.69 56.80 56.55
Only index persons 56.71 56.76 56.52

-FinnGen-

Key figures

All Female Male
Number of individuals 1391 1130 261
Unadjusted period prevalence (%) 0.33 0.39 0.12
Median age at first event (years) 58.95 58.15 62.41

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1219
Matched controls
12190
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M76.0
ICD-10 Finland
Gluteal tendinitis
+∞
323.0
1219
35
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
54.5
243.0
289
69
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
46.0
242.0
298
85
M70.6
ICD-10 Finland
Trochanteric bursitis
11.0
217.3
468
652
M48.0
ICD-10 Finland
Spinal stenosis
60.1
189.8
222
45
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
39.1
167.8
214
66
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
40.1
159.4
202
60
L13
ICPC
Hip symptom/complaint
7.1
159.4
460
953
N03AX16
ATC
pregabalin; oral
6.8
158.8
479
1054
M54.4
ICD-10 Finland
Lumbago with sciatica
9.6
155.6
352
496
M54.5
ICD-10 Finland
Low back pain
5.7
151.3
561
1583
M01AH05
ATC
etoricoxib; oral
5.1
135.7
966
5208
M25.5
ICD-10 Finland
Pain in joint
4.8
131.0
600
2053
N03AX12
ATC
gabapentin; oral
7.7
127.3
330
560
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
178.4
123.9
128
8
N02AX02
ATC
tramadol; systemic, rectal
4.4
123.5
671
2668
M79.6
ICD-10 Finland
Pain in limb
4.2
114.8
641
2558
L03
ICPC
Low back symptom/complaint
4.7
104.8
438
1297
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
27.1
100.4
140
58
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
3.6
95.4
717
3483
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
8.6
94.5
220
304
N02AJ06
ATC
codeine and paracetamol; systemic
3.6
90.3
596
2575
M03BX02
ATC
tizanidine; oral
3.6
88.1
909
5487
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
313.6
86.9
87
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
10.5
83.2
170
185
NF1AA
NOMESCO Finland
Hip X-ray examination
7.3
83.1
216
350
M47.82
ICD-10 Finland
Other spondylosis, cervical region
51.9
80.1
96
20
M75.1
ICD-10 Finland
Rotator cuff syndrome
3.8
79.3
426
1518
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
109.7
75.9
82
8
M76.8
ICD-10 Finland
Other enthesopathies of lower limb, excluding foot
44.6
73.8
91
22
M54.9
ICD-10 Finland
Dorsalgia, unspecified
7.8
72.9
179
264
M16.1
ICD-10 Finland
Other primary coxarthrosis
5.2
67.4
231
524
M54.3
ICD-10 Finland
Sciatica
12.4
64.7
120
106
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
3.1
63.0
450
1922
M01AH01
ATC
celecoxib; oral (coxibs)
3.7
62.8
322
1070
N06AX21
ATC
duloxetine; oral
5.2
62.8
213
475
A02BC05
ATC
esomeprazole; systemic
2.8
62.2
616
3252
M54.1
ICD-10 Finland
Radiculopathy
26.9
59.8
83
33
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
25.7
59.7
84
35
N02BE01
ATC
paracetamol; systemic, rectal
4.2
59.3
1116
8767
M01AB05
ATC
diclofenac; systemic, rectal
2.8
58.0
905
6158
M03BC01
ATC
orphenadrine (citrate); systemic
3.2
55.8
370
1476
M01AC06
ATC
meloxicam; systemic, rectal
2.7
55.7
560
2919
A02BC02
ATC
pantoprazole; systemic
2.7
55.0
878
5943
M79.1
ICD-10 Finland
Myalgia
4.0
53.8
241
703
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
15.1
53.3
90
64
M47.9
ICD-10 Finland
Spondylosis, unspecified
49.2
50.6
61
13
H02AB06
ATC
prednisolone; systemic
2.5
50.4
643
3757
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
29.4
49.6
67
24
M43.1
ICD-10 Finland
Spondylolisthesis
29.0
48.7
66
24
M01AE02
ATC
naproxen; oral, rectal
2.5
48.5
778
5087
M01AE03
ATC
ketoprofen; systemic, rectal
2.5
46.3
517
2773
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.5
45.0
496
2629
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
5.7
44.0
134
259
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
+∞
43.0
41
*
M01AH02
ATC
rofecoxib; oral
3.5
41.9
222
733
M19.0
ICD-10 Finland
Primary arthrosis of other joints
4.2
41.1
171
459
M16.9
ICD-10 Finland
Coxarthrosis, unspecified
5.9
40.9
121
225
N06AA09
ATC
amitriptyline; systemic
4.2
40.5
167
444
L08
ICPC
Shoulder symptom/complaint
2.9
40.1
290
1190
M76.6
ICD-10 Finland
Achilles tendinitis
8.0
39.7
93
125
ABC16
NOMESCO Finland
Microsurgical excision of lumbar intervertebral disc displacement
399.6
39.3
39
*
J01FA10
ATC
azithromycin; systemic
2.2
37.2
789
5536
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
378.2
37.2
37
*
NF1DA
NOMESCO Finland
X-ray of hips
12.4
36.2
66
56
NE1AA
NOMESCO Finland
Pelvis X-ray examination
5.1
36.1
119
251
NFM20
NOMESCO Finland
Excision of bursa of hip or thigh
130.6
35.9
38
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.8
35.1
258
1059
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
18.8
35.1
54
30
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
4.8
34.6
123
281
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
9.5
34.4
72
80
M03BC51
ATC
orphenadrine, combinations; systemic
2.3
34.2
401
2122
NFL30
NOMESCO Finland
Transposition of muscle of hip or thigh
23.1
34.2
49
22
M01AX17
ATC
nimesulide; oral
2.4
33.9
344
1691
M01AX05
ATC
glucosamine; oral
2.6
33.4
288
1296
SPAT1153
SPAT
Removal of sutures
2.3
33.2
426
2346
XA402
NOMESCO Finland
ENMG
10.5
32.9
65
65
NJ3NA
NOMESCO Finland
Measurement of difference in extremity lengty with X-ray
11.0
32.7
63
60
M53.1
ICD-10 Finland
Cervicobrachial syndrome
3.7
32.6
156
470
ABC56
NOMESCO Finland
Decompression of lumbar spinal canal and nerve roots
+∞
32.4
31
*
M70.7
ICD-10 Finland
Other bursitis of hip
7.4
32.4
79
113
M17.1
ICD-10 Finland
Other primary gonarthrosis
2.6
32.2
288
1317
J02AC01
ATC
fluconazole; systemic
2.1
32.0
611
3985
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.9
31.9
140
391
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
31.8
383
2041
R51.80
ICD-10 Finland
Headache
2.9
31.4
213
823
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.4
31.3
308
1483
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
61.7
31.2
36
6
M79.0
ICD-10 Finland
Rheumatism, unspecified
7.5
31.2
75
105
G44.2
ICD-10 Finland
Tension-type headache
2.9
31.1
210
812
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
4.3
30.3
120
305
R03AC02
ATC
salbutamol; inhalant
2.0
30.3
674
4633
M79.7
ICD-10 Finland
Fibromyalgia
6.8
29.9
77
119
M54.2
ICD-10 Finland
Cervicalgia
5.5
29.9
92
179
A02BC03
ATC
lansoprazole; oral
2.2
29.8
390
2146
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.3
29.7
325
1645
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.1
29.6
508
3136
R01AD09
ATC
mometasone; nasal
2.0
29.6
604
3998
M77.1
ICD-10 Finland
Lateral epicondylitis
3.9
29.6
130
363
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.6
29.6
241
1043
R52.2
ICD-10 Finland
Other chronic pain
8.1
29.3
67
87
M54.6
ICD-10 Finland
Pain in thoracic spine
4.8
29.2
101
224
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.9
28.9
197
764
R07.4
ICD-10 Finland
Chest pain, unspecified
2.3
28.6
330
1709
L01
ICPC
Neck symptom/complaint
2.8
28.3
201
800
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
31.7
28.2
37
12
N06AA10
ATC
nortriptyline; systemic
9.1
28.2
60
69
R5599
NOMESCO Finland
Other rehabilitation service
9.1
28.2
60
69
M01AE01
ATC
ibuprofen; systemic, rectal
2.8
28.2
1118
9693
L17
ICPC
Foot/toe symptom/complaint
2.3
28.2
336
1762
M02AA07
ATC
piroxicam; topical
2.0
28.1
485
2986
L28
ICPC
Limited function/disability (L)
2.8
28.0
199
791
J01DB01
ATC
cefalexin; oral
2.2
27.8
1009
8299
L86
ICPC
Back syndrome with radiating pain
6.1
27.7
78
136
A02BC01
ATC
omeprazole; systemic
2.2
27.4
355
1932
J01AA02
ATC
doxycycline; systemic
2.2
27.1
985
8042
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
3.1
27.1
162
574
NHL16
NOMESCO Finland
Tenolysis or tenosynovectomy of achilles tendon
63.5
27.0
31
5
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
4.0
26.8
114
309
M02AA10
ATC
ketoprofen; topical
2.5
26.6
235
1056
H02AB04
ATC
methylprednisolone; systemic
2.6
26.3
222
974
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
3.6
26.2
126
379
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
4.5
25.9
95
224
X58
ICD-10 Finland
Exposure to other specified factors
2.8
25.8
182
717
S18
ICPC
Laceration/cut
1.9
25.4
504
3238
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.9
25.3
695
5020
R06.0
ICD-10 Finland
Dyspnoea
2.2
25.2
304
1592
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
3.7
24.6
113
327
M54
ICD-10 Finland
Dorsalgia
3.0
24.6
153
555
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
4.3
24.5
95
237
Z01.8
ICD-10 Finland
Other specified special examinations
2.2
24.4
282
1445
A06AC01
ATC
ispaghula (psylla seeds); oral
2.1
24.2
335
1856
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
2.8
24.2
166
640
N06AX16
ATC
venlafaxine; oral
2.6
24.1
200
865
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.5
24.0
210
935
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.9
23.9
602
4183
Z01.2
ICD-10 Finland
Dental examination
1.9
23.8
525
3481
N02AA05
ATC
oxycodone; systemic
2.8
23.8
164
636
UKC02
NOMESCO Finland
Cystoscopy
2.7
23.7
177
718
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.7
23.4
179
739
X59
ICD-10 Finland
Exposure to unspecified factor
2.3
23.2
234
1122
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.3
23.2
234
1122
N06AX11
ATC
mirtazapine; oral
2.0
23.1
390
2336
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
11.1
22.7
43
40
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
3.9
22.6
97
265
UJF32
NOMESCO Finland
Coloscopy
2.1
22.4
314
1744
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.9
22.3
149
565
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
2.7
22.3
164
662
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
22.1
493
3256
M76.9
ICD-10 Finland
Enthesopathy of lower limb, unspecified
15.4
22.1
36
24
WX320
NOMESCO Finland
Spinalanesthesy
2.1
22.0
294
1597
SAA02
NOMESCO Finland
Basic examination of mouth
1.8
21.8
773
5945
G55.1*M51.9
ICD-10 Finland
Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)
117.1
21.6
23
*
J45.9
ICD-10 Finland
Asthma, unspecified
2.3
21.5
228
1115
M53.0
ICD-10 Finland
Cervicocranial syndrome
3.2
21.5
118
393
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
5.1
21.4
69
142
J01CA04
ATC
amoxicillin; systemic
2.0
21.2
975
8158
L15
ICPC
Knee symptom/complaint
2.1
21.1
271
1443
R06AE07
ATC
cetirizine; oral
1.8
21.1
564
3942
7227C
ICD-9 Finland
Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]
+∞
20.9
20
*
M50.3
ICD-10 Finland
Other cervical disc degeneration
16.1
20.6
33
21
M54.8
ICD-10 Finland
Other dorsalgia
6.3
20.6
55
90
SAA01
NOMESCO Finland
Simple examination of mouth
1.8
20.6
851
6814
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
13.8
20.6
35
26
M01AB55
ATC
diclofenac, combinations; oral
3.5
20.5
99
299
M76.3
ICD-10 Finland
Iliotibial band syndrome
26.0
20.5
28
11
R01AD08
ATC
fluticasone; nasal
1.9
20.4
381
2346
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
3.1
20.2
115
392
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.9
20.0
336
1990
R52.9
ICD-10 Finland
Pain, unspecified
3.1
19.9
115
397
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
36.4
19.9
25
7
NE1BG
SPAT
NA
12.4
19.6
35
29
M51.9
ICD-10 Finland
Intervertebral disc disorder, unspecified
106.7
19.6
21
*
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
203.0
19.6
20
*
WZA90
NOMESCO Finland
Other doctors statement
2.0
19.2
279
1559
J01DA01
ATC
[U] cefalexin; systemic
1.7
18.8
759
5936
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.9
18.8
332
1992
R05
ICD-10 Finland
Cough
2.1
18.8
255
1384
NAG63
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, more than 3 vertebraea
+∞
18.8
18
*
ABC26
NOMESCO Finland
Open discectomy of lumbar spine
+∞
18.8
18
*
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.8
18.4
504
3495
M01AH03
ATC
valdecoxib; oral
3.4
18.4
93
291
R01BA52
ATC
pseudoephedrine, combinations; oral
1.8
18.2
420
2757
R01AD12
ATC
fluticasone furoate; nasal
1.8
18.2
385
2460
L16
ICPC
Ankle symptom/complaint
2.6
18.1
141
583
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
8.2
18.1
40
50
D07AC13
ATC
mometasone; topical
1.9
18.1
355
2208
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
18.0
599
4401
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
2.0
18.0
275
1560
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
3.9
17.9
75
201
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.1
17.9
101
342
SPAT1212
SPAT
Extensive examination of musculoskeletal system
3.0
17.9
111
400
WX110
NOMESCO Finland
Local anesthesy
1.7
17.7
817
6586
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
5.7
17.7
51
93
M77.4
ICD-10 Finland
Metatarsalgia
3.3
17.6
90
284
Z01.9
ICD-10 Finland
Special examination, unspecified
3.4
17.6
88
273
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.0
17.6
72
189
N04BC05
ATC
pramipexole; oral
3.1
17.6
101
347
R42
ICD-10 Finland
Dizziness and giddiness
2.0
17.4
252
1399
N03AE01
ATC
clonazepam; systemic
3.6
17.2
79
229
L02
ICPC
Back symptom/complaint
2.8
17.2
114
430
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
2.8
17.2
115
434
J01FA09
ATC
clarithromycin; systemic
1.8
17.1
400
2628
J01FA06
ATC
roxithromycin; oral
1.7
17.0
507
3583
G55.1
ICD-10 Finland
Nerve root and plexus compressions in intervertebral disc disorders
50.7
17.0
20
*
J01MA02
ATC
ciprofloxacin; systemic
1.7
17.0
434
2927
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.9
17.0
286
1678
G04BD12
ATC
mirabegron; oral
2.5
16.9
135
569
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.5
16.8
134
564
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.7
16.8
519
3706
B01AF01
ATC
rivaroxaban; oral
2.4
16.7
148
659
P01AB01
ATC
metronidazole; oral, rectal
1.7
16.6
507
3603
M24.8
ICD-10 Finland
Other specific joint derangements, not elsewhere classified
23.4
16.5
23
10
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
7.9
16.4
37
48
A02BA02
ATC
ranitidine; systemic
2.0
16.4
232
1275
L29
ICPC
Musculoskeletal sympt/complt other
2.9
16.3
104
384
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.7
16.3
114
444
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
15.6
16.2
26
17
ZXA00
NOMESCO Finland
Right side
1.8
16.2
313
1924
M77.9
ICD-10 Finland
Enthesopathy, unspecified
4.7
16.1
55
122
NFL20
NOMESCO Finland
Freeing of muscle of hip or thigh
48.2
16.0
19
*
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.0
16.0
216
1163
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
3.5
16.0
75
222
R21
ICPC
Throat symptom/complaint
2.0
16.0
238
1334
A06AD11
ATC
lactulose; oral
2.4
15.8
147
669
NBG10
NOMESCO Finland
Acromioplastia
5.6
15.8
46
85
G56.2
ICD-10 Finland
Lesion of ulnar nerve
5.1
15.8
50
102
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
11.4
15.8
29
26
M43.0
ICD-10 Finland
Spondylolysis
60.8
15.8
18
*
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
4.9
15.6
51
108
N05CF01
ATC
zopiclone; oral
1.8
15.6
362
2361
H02AB07
ATC
prednisone; oral
2.2
15.5
181
913
H02BX01
ATC
methylprednisolone, combinations; systemic
3.6
15.5
71
206
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
6.7
15.5
39
60
E0000UV
ATC
NA
1.7
15.4
469
3308
Z00.0
ICD-10 Finland
General medical examination
2.0
15.4
217
1187
M01AB08
ATC
etodolac; oral
2.8
15.3
103
392
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
2.3
15.3
146
671
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.6
15.3
119
494
G57.1
ICD-10 Finland
Meralgia paraesthetica
10.6
15.2
29
28
NB1BG
NOMESCO Finland
Shoulder and humerus MRI examination with high intensity magnet
5.9
15.2
42
73
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
15.2
306
1903
S76.3
ICD-10 Finland
Injury of muscle and tendon of the posterior muscle group at thigh level
7.9
15.1
34
44
R52.1
ICD-10 Finland
Chronic intractable pain
23.7
15.1
21
9
A01
ICPC
Pain general/multiple sites
2.8
15.1
97
359
M51.8
ICD-10 Finland
Other specified intervertebral disc disorders
45.6
15.1
18
*
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.3
15.0
142
651
C07AB07
ATC
bisoprolol; oral
1.7
15.0
493
3544
UJF30
NOMESCO Finland
Ileoscopy through colon
2.5
15.0
123
525
SPAT1263
SPAT
Sampling
1.7
14.9
474
3375
M79.9
ICD-10 Finland
Soft tissue disorder, unspecified
12.6
14.9
26
21
N06AB04
ATC
citalopram; systemic
1.9
14.8
256
1511
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
13.4
14.7
25
19
L89
ICPC
Osteoarthrosis of hip
4.2
14.7
55
134
C05AA08
ATC
fluocortolone; rectal, topical
2.1
14.6
187
985
M16.3
ICD-10 Finland
Other dysplastic coxarthrosis
11.0
14.5
27
25
XQ800
NOMESCO Finland
Prick test
2.7
14.5
102
400
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
14.5
401
2742
N05BA04
ATC
oxazepam; oral
1.8
14.4
297
1854
WX290
NOMESCO Finland
Other blockade of nerve
1.6
14.4
502
3656
ZXA05
NOMESCO Finland
Left side
1.8
14.4
292
1814
SPAT1310
SPAT
Counselling related to known health issue
1.7
14.3
358
2374
K02.1
ICD-10 Finland
Caries of dentine
1.6
14.2
644
5014
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
14.1
276
1691
M76.1
ICD-10 Finland
Psoas tendinitis
43.0
14.1
17
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.0
14.1
82
285
WX002
NOMESCO Finland
Sedation and analgesia
1.9
14.0
240
1408
R03AK07
ATC
formoterol and budesonide; inhalant
1.9
14.0
243
1432
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.6
13.9
669
5277
ACC51
NOMESCO Finland
Release of median nerve
2.7
13.9
98
385
M16
ICD-10 Finland
Coxarthrosis [arthrosis of hip]
3.3
13.8
69
215
B01AB05
ATC
enoxaparin; parenteral
1.7
13.8
349
2319
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
3.0
13.6
82
289
NAG66
NOMESCO Finland
Posterior interbody fusion of lumbar spine, 2 vertebrae
+∞
13.6
13
*
ZXM20
NOMESCO Finland
Intraoperative use of computerised tomography
34.4
13.5
17
5
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.3
13.4
131
607
M75.2
ICD-10 Finland
Bicipital tendinitis
5.2
13.4
41
81
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.1
13.4
156
787
NFF25
NOMESCO Finland
Cleaning of hip joint, arthroscopic
26.0
13.4
18
7
G54.0
ICD-10 Finland
Brachial plexus disorders
6.0
13.4
36
61
Z50.1
ICD-10 Finland
Other physical therapy
3.2
13.3
69
221
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
2.1
13.1
152
764
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
2.3
13.1
127
589
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
13.1
174
928
J02AC02
ATC
itraconazole; systemic
1.8
13.0
237
1417
SPAT1216
SPAT
Assessment of functional ability
2.1
13.0
164
856
NE1CG
SPAT
NA
28.7
13.0
17
6
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.7
13.0
325
2148
R35
ICD-10 Finland
Polyuria
3.2
13.0
69
226
M23.8
ICD-10 Finland
Other internal derangements of knee
3.8
12.9
54
146
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.3
12.9
120
545
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
3.6
12.8
58
168
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.6
12.8
639
5040
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
3.3
12.7
64
201
M77.0
ICD-10 Finland
Medial epicondylitis
5.1
12.7
39
78
NA1AD
NOMESCO Finland
Cervical spine CT examination
4.2
12.7
48
119
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
12.6
381
2649
R06AE09
ATC
levocetirizine; oral
2.0
12.6
180
987
WX308
NOMESCO Finland
Sacral anesthesy
+∞
12.5
12
*
N05BA12
ATC
alprazolam; oral
2.2
12.5
130
623
A03FA02
ATC
cisapride; oral, rectal
2.6
12.5
92
369
S86.0
ICD-10 Finland
Injury of Achilles tendon
6.1
12.5
33
55
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
2.4
12.4
112
500
D07AC01
ATC
betamethasone; topical
1.6
12.4
380
2646
L14
ICPC
Leg/thigh symptom/complaint
2.6
12.4
92
372
N01
ICPC
Headache
2.3
12.4
115
524
R03DC03
ATC
montelukast; oral
1.9
12.3
204
1177
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.0
12.3
156
814
G47.3
ICD-10 Finland
Sleep apnoea
1.8
12.3
219
1297
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.9
12.2
190
1074
M45
ICD-10 Finland
Ankylosing spondylitis
37.9
12.2
15
*
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.6
12.1
453
3315
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.4
12.1
103
449
R07.3
ICD-10 Finland
Other chest pain
2.4
12.1
108
482
J05AB01
ATC
aciclovir; systemic
1.8
12.1
260
1634
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
12.1
269
1708
R03AC13
ATC
formoterol; inhalant
3.0
12.1
70
243
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
3.6
12.1
54
155
M35.7
ICD-10 Finland
Hypermobility syndrome
8.8
12.0
25
29
N05BA01
ATC
diazepam; systemic, rectal
2.1
12.0
146
747
N05CF02
ATC
zolpidem; oral
1.8
12.0
215
1274
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.6
12.0
472
3499
D07AB02
ATC
hydrocortisone butyrate; topical
1.7
12.0
325
2186
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
4.7
11.9
40
88
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.7
11.9
315
2104
NF1AA
SPAT
NA
4.2
11.9
44
107
AA1AD
NOMESCO Finland
CT of head and brain
1.8
11.9
243
1506
D06
ICPC
Abdominal pain localized other
2.4
11.8
101
441
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.6
11.8
385
2721
D82
ICPC
Teeth/gum disease
1.6
11.8
396
2821
Z71.8
ICD-10 Finland
Other specified counselling
1.7
11.7
263
1676
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
11.7
222
1342
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.5
11.6
589
4621
Z3226
NOMESCO Finland
Physiotherapist
1.8
11.6
205
1207
R03BA05
ATC
fluticasone; inhalant
1.8
11.6
215
1289
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
4.7
11.6
38
82
XG410
NOMESCO Finland
Flow-volume spirometry
3.3
11.6
57
177
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
5.2
11.6
35
69
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
3.0
11.6
67
233
A02BC04
ATC
rabeprazole; oral
2.3
11.6
114
533
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.1
11.5
132
659
S83.2
ICD-10 Finland
Tear of meniscus, current
2.6
11.5
84
337
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.6
11.5
84
337
L12
ICPC
Hand/finger symptom/complaint
2.0
11.5
162
880
H04.10
ICD-10 Finland
Dry eye syndrome
2.1
11.5
134
675
72870
ICD-8 Finland
Vertebrogenic pain syndrome, Lumbalgia
+∞
11.5
11
*
9211
FHL
Exploration or removal of diskusprolapse
+∞
11.5
11
*
NA3CF
NOMESCO Finland
Lumbar spine extensive MRI examination with median intensity magnet
+∞
11.5
11
*
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
2.2
11.5
118
562
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.7
11.5
79
306
NAU20
NOMESCO Finland
Removal of internal fixation device from spine or neck
121.1
11.4
12
*
E66.01
ICD-10 Finland
Obesity due to excess calories
2.4
11.4
95
409
M01AB51
ATC
indometacin, combinations; oral, rectal
5.4
11.4
33
62
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
2.1
11.3
133
674
R05
ICPC
Cough
1.7
11.3
253
1611
NBG00
NOMESCO Finland
Plastic operation on acromioclavicular joint
6.0
11.2
30
51
R13
ICD-10 Finland
Dysphagia
2.7
11.2
77
296
M18.1
ICD-10 Finland
Other primary arthrosis of first carpometacarpal joint
4.8
11.2
36
76
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.8
11.2
73
272
R03BA01
ATC
beclometasone; inhalant
1.9
11.2
160
877
SAA03
NOMESCO Finland
Extended examination of mouth
1.6
11.2
422
3084
C01CA24
ATC
epinephrine; parenteral
2.6
11.1
80
316
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.8
11.1
213
1291
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.5
11.1
559
4365
NA3BG
SPAT
NA
5.3
11.1
33
64
M01AX01
ATC
nabumetone; oral
3.2
11.1
58
189
G04BD08
ATC
solifenacin; oral
2.6
11.0
80
319
R03BA08
ATC
ciclesonide; inhalant
2.2
10.9
110
520
K30
ICD-10 Finland
Functional dyspepsia
2.1
10.9
121
597
G57.6
ICD-10 Finland
Lesion of plantar nerve
4.4
10.8
38
88
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
2.2
10.8
114
551
M13.9
ICD-10 Finland
Arthritis, unspecified
2.5
10.8
85
355
M89.0
ICD-10 Finland
Algoneurodystrophy
9.7
10.8
21
22
RF410
NOMESCO Finland
NA
7.6
10.7
24
32
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.4
10.7
90
390
M47.1
ICD-10 Finland
Other spondylosis with myelopathy
60.5
10.6
12
*
NBF25
NOMESCO Finland
Operation for humeroscapular osteochondritis, arthroscopic
4.8
10.6
34
72
R06AX27
ATC
desloratadine; oral
1.6
10.5
325
2253
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
2.9
10.5
63
226
RF210
NOMESCO Finland
NA
3.8
10.4
43
116
AB5BT
NOMESCO Finland
Blockage of nerv root with X-ray guidance
+∞
10.4
10
*
72510
ICD-8 Finland
Displacement of intervertebral disk, Lumbalis cum prolapsu disci
+∞
10.4
10
*
72880
ICD-8 Finland
Vertebrogenic pain syndrome, Radicula syndrome of lower limbs
+∞
10.4
10
*
M53.2
ICD-10 Finland
Spinal instabilities
+∞
10.4
10
*
R05FB02
ATC
cough suppressants and expectorants
1.5
10.4
440
3289
D07AD01
ATC
clobetasol; topical
1.8
10.4
188
1116
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.1
10.3
124
634
SDA02
NOMESCO Finland
Parodonthologic therapy
1.6
10.3
372
2678
J01FF01
ATC
clindamycin; systemic
1.6
10.3
299
2037
TAB20
NOMESCO Finland
Epidural puncture
19.0
10.3
15
8
N06AX03
ATC
mianserin; oral
3.0
10.2
59
205
K59.0
ICD-10 Finland
Constipation
2.9
10.2
63
227
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
2.5
10.2
81
339
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
2.7
10.2
68
259
S01GX01
ATC
cromoglicic acid; ophthalmic
1.7
10.2
250
1628
SPAT1211
SPAT
Application of soft bandage
2.2
10.2
105
503
M24.2
ICD-10 Finland
Disorder of ligament
6.0
10.1
27
46
R53
ICD-10 Finland
Malaise and fatigue
1.7
10.1
206
1269
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
2.8
10.1
63
231
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
4.4
10.0
35
81
N81.6
ICD-10 Finland
Rectocele
2.2
10.0
101
476
XKD00
NOMESCO Finland
Uroflowmetry
2.1
10.0
111
550
D01
ICPC
Abdominal pain/cramps general
2.1
10.0
119
606
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
2.6
10.0
71
282
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.5
9.9
519
4051
S22.3
ICD-10 Finland
Fracture of rib
2.9
9.9
60
216
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
3.5
9.9
45
132
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.5
9.9
423
3160
R01AD11
ATC
triamcinolone; nasal
2.1
9.9
114
573
NH4AE
NOMESCO Finland
Achilles tendon ultrasound examination
20.2
9.8
14
7
A02BA04
ATC
nizatidine; systemic
2.3
9.7
85
377
N02AJ13
ATC
tramadol and paracetamol; systemic
5.4
9.7
28
53
H93.1
ICD-10 Finland
Tinnitus
2.4
9.7
81
350
WX200
NOMESCO Finland
Interscalenous plexus blockade
4.8
9.7
31
66
AB5CT
NOMESCO Finland
Blockage of nerv root with CT guidance
55.4
9.7
11
*
S04
ICPC
Lump/swelling localized
2.1
9.6
110
549
M09AX01
ATC
hyaluronic acid; parenteral
2.9
9.6
57
203
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
2.1
9.6
116
592
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
4.2
9.6
35
85
C09CA06
ATC
candesartan; oral
1.7
9.6
240
1571
SPAT1301
SPAT
No procedures
1.6
9.5
321
2265
L11
ICPC
Wrist symptom/complaint
2.2
9.5
98
468
SPAT1260
SPAT
Consultation of another employee
1.8
9.5
186
1131
R60.0
ICD-10 Finland
Localized oedema
2.0
9.4
117
604
M65.3
ICD-10 Finland
Trigger finger
2.8
9.4
59
216
J01MA12
ATC
levofloxacin; systemic
1.8
9.4
187
1143
ABC30
NOMESCO Finland
Decompression of cervical nerve roots
100.7
9.4
10
*
M50.9
ICD-10 Finland
Cervical disc disorder, unspecified
30.3
9.4
12
*
NA3SA
NOMESCO Finland
Lumbar spine X-ray examination in standing position
30.3
9.4
12
*
7245A
ICD-9 Finland
Other and unspecified disorders of back, Backache, unspecified
+∞
9.4
9
*
G54.4
ICD-10 Finland
Lumbosacral root disorders, not elsewhere classified
+∞
9.4
9
*
M48
ICD-10 Finland
Other spondylopathies
+∞
9.4
9
*
NAG65
NOMESCO Finland
Anterior and posterior fusion of lumbar spine
+∞
9.4
9
*
XG474
NOMESCO Finland
Exhalation nntrogen oxide
3.4
9.4
44
133
ABD32
NOMESCO Finland
Implantation of temporary spinal stimulation device
21.9
9.4
13
6
C10AX09
ATC
ezetimibe; oral
2.1
9.3
106
530
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.6
9.3
288
1989
H01
ICPC
Ear pain/earache
2.0
9.3
114
586
M15
ICD-10 Finland
Polyarthrosis
2.6
9.3
64
250
NF2AT
NOMESCO Finland
Injection to hip joint with ultrasound guidance
10.8
9.3
17
16
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.8
9.3
174
1042
R06AX13
ATC
loratadine; oral
1.8
9.3
182
1106
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.1
9.2
105
524
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
5.5
9.2
26
48
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
3.1
9.2
48
157
M20.1
ICD-10 Finland
Hallux valgus (acquired)
2.0
9.2
117
610
XKD03
NOMESCO Finland
Urethral pressure profilometry
3.7
9.2
38
104
WX702
NOMESCO Finland
Supraglottic ventilation device
2.6
9.1
68
275
NBA30
NOMESCO Finland
Exploration of joint of shoulder or upper arm, arthroscopic
3.5
9.1
41
120
A98
ICPC
Health maint/preventive medicine
2.5
9.1
1181
11273
NGF00
NOMESCO Finland
Excision of plica of synovy of knee
4.2
9.1
33
80
XKC03
NOMESCO Finland
Water cystometry
3.4
9.1
43
131
KMAK
NOMESCO Finland
NA
1.4
9.0
584
4729
M02AA15
ATC
diclofenac; topical (antiinflammatory prep., non-steroids for topical use)
2.2
9.0
92
436
M51.2
ICD-10 Finland
Other specified intervertebral disc displacement
37.0
9.0
11
*
-1
NOMESCO Finland
NA
1.5
9.0
354
2584
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
2.9
8.9
52
183
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.8
8.9
159
935
R06AX22
ATC
ebastine; oral
1.7
8.9
211
1356
J31.0
ICD-10 Finland
Chronic rhinitis
2.2
8.8
89
423
S43.4
ICD-10 Finland
Sprain and strain of shoulder joint
3.3
8.8
42
129
9476
FHL
Splitting of fascia or aponeurosis
10.8
8.8
16
15
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.9
8.8
124
674
R02
ICPC
Shortness of breath/dyspnoea
1.9
8.8
122
659
C07AA05
ATC
propranolol; systemic
1.6
8.8
222
1453
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
3.9
8.8
34
88
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.2
8.8
88
416
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
2.7
8.7
59
227
M75
ICD-10 Finland
Shoulder lesions
2.8
8.7
55
203
S06.0
ICD-10 Finland
Concussion
2.0
8.7
106
545
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
8.7
312
2224
NFE15
NOMESCO Finland
Plastic repair of capsule or ligament of hip joint
50.3
8.7
10
*
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
3.6
8.7
37
104
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.2
8.7
85
398
R74
ICPC
Upper respiratory infection acute
1.5
8.7
301
2132
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
3.2
8.6
44
142
RF420
NOMESCO Finland
NA
6.2
8.6
22
36
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.6
8.6
274
1901
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
2.7
8.6
56
212
M01AB16
ATC
aceclofenac; oral
3.2
8.6
43
137
M01AC01
ATC
piroxicam; systemic, rectal
1.8
8.6
146
846
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
8.3
8.6
18
22
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
4.1
8.6
32
80
M65.9
ICD-10 Finland
Synovitis and tenosynovitis, unspecified
3.7
8.6
36
100
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.3
8.5
77
347
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.0
8.5
113
601
I49.3
ICD-10 Finland
Ventricular premature depolarization
2.3
8.5
79
359
M54.0
ICD-10 Finland
Panniculitis affecting regions of neck and back
9.1
8.5
17
19
J01MA06
ATC
norfloxacin; oral
1.7
8.5
166
1007
ZZH40
NOMESCO Finland
Substitute of bone
10.1
8.5
16
16
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
1.9
8.5
122
666
N30.0
ICD-10 Finland
Acute cystitis
1.8
8.5
154
913
M75.5
ICD-10 Finland
Bursitis of shoulder
4.0
8.5
32
81
M21.7
ICD-10 Finland
Unequal limb length (acquired)
90.6
8.4
9
*
Z04.3
ICD-10 Finland
Examination and observation following other accident
4.5
8.4
28
63
J01DA06
ATC
[U] cefuroxime; systemic
1.7
8.4
169
1034
R60.9
ICD-10 Finland
Oedema, unspecified
2.8
8.3
53
197
N06AB10
ATC
escitalopram; oral
1.6
8.3
215
1413
NG2AA
NOMESCO Finland
Patella X-ray examination
3.4
8.3
38
113
NFG00
NOMESCO Finland
Arthroplasty of hip joint
+∞
8.3
8
*
7231A
ICD-9 Finland
Other disorders of cervical region, Cervicalgia
+∞
8.3
8
*
J01AA04
ATC
lymecycline; systemic
1.8
8.3
154
917
ZSN00
NOMESCO Finland
Procedure related to previous procedure classified in chapter N
9.5
8.3
16
17
N39.3
ICD-10 Finland
Stress incontinence
2.0
8.3
105
550
D11
ICPC
Diarrhoea
1.9
8.3
118
644
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.0
8.2
102
527
R05FA02
ATC
opium derivatives and expectorants; systemic
1.4
8.2
467
3668
N02AC04
ATC
dextropropoxyphene; oral
3.7
8.2
34
94
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.8
8.2
49
177
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.5
8.2
293
2089
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.7
8.1
183
1158
NGF35
NOMESCO Finland
Plastic operation of joint cartilage of knee
3.0
8.1
44
149
NG1BA
NOMESCO Finland
Knee extensive X-ray examination
4.2
8.1
29
70
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
2.1
8.1
91
454
G43.9
ICD-10 Finland
Migraine, unspecified
2.5
8.1
62
257
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
17.3
8.1
12
7
M25.2
ICD-10 Finland
Flail joint
6.9
8.1
19
28
R01AD01
ATC
beclometasone; nasal
1.7
8.1
179
1126
XQ802
NOMESCO Finland
Epicutan test
2.7
8.1
52
196
N05BB01
ATC
hydroxyzine; systemic
2.3
8.1
73
328
R03BA02
ATC
budesonide; inhalant
1.7
8.1
193
1244
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.5
8.1
338
2494
S76.4
ICD-10 Finland
Injury of other and unspecified muscles and tendons at thigh level
10.1
8.0
15
15
S79.9
ICD-10 Finland
Unspecified injury of hip and thigh
10.1
8.0
15
15
NE1BA
NOMESCO Finland
Pelvis extensive X-ray examination
4.6
8.0
26
57
M65.8
ICD-10 Finland
Other synovitis and tenosynovitis
3.5
8.0
35
101
D19
ICPC
Teeth/gum symptom/complaint
1.5
8.0
291
2077
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.1
8.0
90
450
SPAT1229
SPAT
Assessment of need for aid
2.3
8.0
75
344
N05AH04
ATC
quetiapine; oral
1.7
7.9
159
972
DFF00
NOMESCO Finland
Pure tone audiometry
2.0
7.9
104
551
S93.4
ICD-10 Finland
Sprain and strain of ankle
2.0
7.9
100
522
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.4
7.9
64
273
1410
FHL
Laparoscopy
2.9
7.9
47
169
M41.9
ICD-10 Finland
Scoliosis, unspecified
13.1
7.9
13
10
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
13.1
7.9
13
10
G04BD09
ATC
trospium; oral
3.5
7.8
35
103
M01AB01
ATC
indometacin; systemic, rectal
2.4
7.8
66
286
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.1
7.8
41
136
M70.9
ICD-10 Finland
Unspecified soft tissue disorder related to use, overuse and pressure
8.5
7.8
16
19
SPAT1106
SPAT
Acupuncture
8.5
7.8
16
19
K08.80
ICD-10 Finland
Toothache NOS
2.0
7.8
93
475
A06AC51
ATC
ispaghula, combinations; systemic
2.4
7.7
63
270
SPAT1312
SPAT
General health counselling
1.5
7.7
330
2437
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
2.2
7.7
76
357
C10AA07
ATC
rosuvastatin; oral
1.6
7.7
245
1698
G01AF05
ATC
econazole; vaginal
1.8
7.7
126
721
RD211
NOMESCO Finland
NA
2.5
7.7
59
244
R20.2
ICD-10 Finland
Paraesthesia of skin
2.3
7.6
69
313
M01AC02
ATC
tenoxicam; systemic, rectal
2.4
7.6
62
264
J45.1
ICD-10 Finland
Nonallergic asthma
2.2
7.6
76
360
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.5
7.6
34
100
L19
ICPC
Muscle symptom/complaint NOS
3.5
7.6
34
100
D01AC03
ATC
econazole; topical
2.3
7.6
68
306
L10
ICPC
Elbow symptom/complaint
2.7
7.6
49
185
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
4.1
7.6
28
70
M53.9
ICD-10 Finland
Dorsopathy, unspecified
25.2
7.6
10
*
J37.0
ICD-10 Finland
Chronic laryngitis
3.0
7.6
43
148
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
4.3
7.5
26
61
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
4.2
7.5
27
66
78551
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD
3.1
7.5
39
129
C08CA05
ATC
nifedipine; systemic
2.4
7.5
61
260
R49.08
ICD-10 Finland
Other specified dysphonia
4.0
7.5
28
71
W19
ICD-10 Finland
Unspecified fall
2.0
7.5
88
446
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.4
7.5
62
270
N06AB05
ATC
paroxetine; oral
2.2
7.4
74
348
NA6CG
NOMESCO Finland
Sacro-iliac joint extensive MRI examination with high intensity magnet
80.5
7.4
8
*
KCV04
NOMESCO Finland
Distension of bladder with fluid
6.5
7.4
18
28
H02AB01
ATC
betamethasone; systemic
13.4
7.4
12
9
M01AE52
ATC
naproxen and esomeprazole; oral
3.0
7.4
42
145
J01DC02
ATC
cefuroxime; systemic
2.2
7.4
72
339
S82
ICPC
Naevus/mole
1.8
7.4
137
817
R51
ICD-10 Finland
Headache
2.4
7.3
58
246
NK4EA
NOMESCO Finland
Joint X-ray examintion with load or wrench not elsewhere classified
6.9
7.3
17
25
NBL22
NOMESCO Finland
Myotomy, tenotomy or excision of tendon of upper arm
4.5
7.3
24
54
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.7
7.3
138
830
M03AX01
ATC
botulinum toxin; parenteral
5.2
7.3
21
41
R96
ICPC
Asthma
1.9
7.3
97
519
M01AG02
ATC
tolfenamic acid; oral, rectal
1.6
7.2
198
1318
R4110
NOMESCO Finland
Physiotherapy
1.5
7.2
272
1950
M35.3
ICD-10 Finland
Polymyalgia rheumatica
3.1
7.2
38
127
M53.3
ICD-10 Finland
Sacrococcygeal disorders, not elsewhere classified
7.4
7.2
16
22
A97
ICPC
No disease
1.7
7.2
152
943
N03AX09
ATC
lamotrigine; oral
2.5
7.2
53
215
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
3.2
7.2
35
111
M50.8
ICD-10 Finland
Other cervical disc disorders
30.2
7.2
9
*
Y79.2
ICD-10 Finland
Orthopaedic devices associated with adverse incidents, prosthetic and other implants, materials and accessory devices
30.2
7.2
9
*
SGA01
NOMESCO Finland
Tooth opening as first aid
1.7
7.1
167
1065
S70.0
ICD-10 Finland
Contusion of hip
3.1
7.1
36
117
G44.0
ICD-10 Finland
Cluster headache syndrome
6.6
7.1
17
26
K07
ICPC
Swollen ankles/oedema
2.9
7.1
41
144
N06AB03
ATC
fluoxetine; oral
1.7
7.0
141
862
JN3AD
NOMESCO Finland
Abdominal CT examination
2.1
7.0
78
385
N17
ICPC
Vertigo/dizziness
1.8
7.0
112
639
XX9CW
NOMESCO Finland
Submitting image material and/or investigation material to patient
7.0
7.0
16
23
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.8
7.0
42
153
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
3.7
7.0
28
76
NB2AT
NOMESCO Finland
Intra artrial injection of shoulder with ultrasound guidance
4.9
7.0
21
43
TQW40
NOMESCO Finland
Remowal of suture of skin
2.0
7.0
82
416
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.7
7.0
132
794
J01FA15
ATC
telithromycin; oral
1.8
7.0
122
717
XF402
NOMESCO Finland
ECG with work load test
1.9
6.9
106
595
A27
ICPC
Fear of other disease NOS
2.5
6.9
50
203
M71.2
ICD-10 Finland
Synovial cyst of popliteal space [Baker]
2.8
6.9
41
148
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.3
6.9
58
254
S29
ICPC
Skin symptom/complaint other
1.6
6.9
168
1087
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.0
6.9
90
477
A01AB04
ATC
amphotericin B; local oral
2.4
6.9
53
223
SPAT1097
SPAT
Recording of ECG
1.7
6.9
151
949
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
2.9
6.9
40
142
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
2.8
6.9
41
149
NDG60
NOMESCO Finland
Arthroplasty of first CMC joint
4.4
6.9
23
53
NDL52
NOMESCO Finland
Tenosynovectomy of hand
8.3
6.8
14
17
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
6.8
139
855
R1250
NOMESCO Finland
Evaluation of functional capability
4.0
6.8
25
63
G01AF01
ATC
metronidazole; vaginal
1.7
6.8
148
927
SPAT1043
SPAT
Audiometry
1.9
6.8
99
548
NFA30
NOMESCO Finland
Exploration of hip joint, arthroscopic
40.3
6.8
8
*
K04
ICPC
Palpitations/awareness of heart
2.3
6.7
60
271
ZXD20
NOMESCO Finland
Day surgery
1.7
6.7
143
888
K80
ICPC
Cardiac arrhythmia NOS
2.0
6.7
81
417
N02CC03
ATC
zolmitriptan; nasal, oral
2.1
6.7
72
353
R03BC03
ATC
nedocromil; inhalant
1.9
6.7
89
475
K02.0
ICD-10 Finland
Caries limited to enamel
1.7
6.7
138
851
LEF03
NOMESCO Finland
Posterior colporrpahy with sutures for primary rectocele
2.3
6.7
59
264
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
3.0
6.7
36
123
B01AC04
ATC
clopidogrel; oral
1.8
6.7
121
716
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.2
6.7
67
320
B01AX06
ATC
[U] rivaroxaban; oral
3.4
6.7
30
90
XF404
NOMESCO Finland
Ambulatory ECG
1.9
6.7
94
513
D02
ICPC
Abdominal pain epigastric
2.2
6.6
64
299
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
2.7
6.6
41
153
N07CA01
ATC
betahistine; oral
2.0
6.6
78
399
SPAT1325
SPAT
Vaccination
1.4
6.6
347
2660
H57.1
ICD-10 Finland
Ocular pain
2.8
6.6
39
141
R12
ICD-10 Finland
Heartburn
2.0
6.6
77
391
R09
ICPC
Sinus symptom/complaint
1.9
6.5
87
463
ND1AA
NOMESCO Finland
Wrist X-ray examination
2.1
6.5
70
341
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.2
6.5
63
294
F45.8
ICD-10 Finland
Other somatoform disorders
2.0
6.5
75
379
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.8
6.5
111
643
R03AK08
ATC
formoterol and beclometasone; inhalant
2.6
6.5
44
173
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.8
6.5
38
136
J01CA08
ATC
pivmecillinam; oral
1.4
6.5
508
4175
G04BD11
ATC
fesoterodine; oral
3.0
6.5
35
120
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
2.1
6.4
67
323
M48.9
ICD-10 Finland
Spondylopathy, unspecified
70.2
6.4
7
*
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
70.2
6.4
7
*
R50.9
ICD-10 Finland
Fever, unspecified
1.7
6.4
129
790
Z30.2
ICD-10 Finland
Sterilization
1.7
6.4
129
791
OAA65
SPAT
NA
1.9
6.4
96
536
G50.1
ICD-10 Finland
Atypical facial pain
3.9
6.4
24
62
Z54.0
ICD-10 Finland
Convalescence following surgery
3.9
6.4
24
62
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
3.3
6.4
29
88
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.0
6.4
82
433
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.3
6.4
54
237
K07.60
ICD-10 Finland
Snapping jaw
2.3
6.4
54
237
M20.5
ICD-10 Finland
Other deformities of toe(s) (acquired)
6.6
6.3
15
23
NGM10
NOMESCO Finland
Fasciotomy of of knee or lower leg
8.2
6.3
13
16
A09
ICPC
Sweating problem
5.2
6.3
18
35
N03AF01
ATC
carbamazepine; oral, rectal
2.3
6.3
54
239
M21.4
ICD-10 Finland
Flat foot [pes planus] (acquired)
2.8
6.3
37
133
A03CA02
ATC
clidinium and psycholeptics; oral
2.2
6.3
62
294
L83
ICPC
Neck syndrome
9.3
6.3
12
13
S76.0
ICD-10 Finland
Injury of muscle and tendon of hip
9.3
6.3
12
13
R55
ICD-10 Finland
Syncope and collapse
1.9
6.3
95
532
A99
ICPC
Disease/condition unspecnature/site
1.9
6.3
85
456
M47.81
ICD-10 Finland
Other spondylosis, occipito-atlanto-axial region
18.1
6.3
9
5
ABC50
NOMESCO Finland
Decopression of cervical spinal canal and nerve roots
+∞
6.3
6
*
NA7BT
NOMESCO Finland
Injection to spinal facet joint with radiological guidance
+∞
6.3
6
*
M48.8
ICD-10 Finland
Other specified spondylopathies
+∞
6.3
6
*
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
2.9
6.3
36
127
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.6
6.2
44
175
L84
ICPC
Back syndrome without radiat pain
2.6
6.2
41
158
N29
ICPC
Neurological sympt/complt other
4.3
6.2
21
49
Q65.88
ICD-10 Finland
Other congenital deformities of hip
26.8
6.2
8
*
M20.2
ICD-10 Finland
Hallux rigidus
2.7
6.2
38
141
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.1
6.2
68
336
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.7
6.2
122
741
G03FA01
ATC
norethisterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
1.6
6.2
177
1187
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.5
6.2
45
184
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
3.6
6.2
26
74
M75.9
ICD-10 Finland
Shoulder lesion, unspecified
2.4
6.2
48
203
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.9
6.2
83
446
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.1
6.2
70
351
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
6.3
6.2
15
24
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.2
6.2
61
290
C07AB02
ATC
metoprolol; systemic
1.6
6.2
185
1257
NHK30
NOMESCO Finland
Osteotomy or rotation osteotomy of first metatarsal or tarsal bone
2.3
6.1
53
236
S01GX02
ATC
levocabastine; ophthalmic
2.0
6.1
74
382
K03.64
ICD-10 Finland
Dental calculus supragingival
1.4
6.1
294
2212
NFB50
NOMESCO Finland
Primary total prosthetic replacement of hip joint using cement
4.7
6.1
19
41
M53.8
ICD-10 Finland
Other specified dorsopathies
12.6
6.1
10
8
G04CA01
ATC
alfuzosin; oral
2.1
6.0
62
298
R49.01
ICD-10 Finland
Functional dysphonia
2.7
6.0
37
138
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.2
6.0
58
273
EMB10
NOMESCO Finland
Tonsillectomy
2.2
6.0
58
273
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.2
6.0
57
264
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
2.1
6.0
62
299
G01AF04
ATC
miconazole; vaginal
2.0
6.0
69
349
SPAT1240
SPAT
Therapeutic discussion
1.8
6.0
96
546

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
432
1808
3.02
72.71
1.4
1.2
u/ml
6.5
12.9
1.65
127
701
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
431
1913
2.82
63.90
1.4
1.2
iu/ml
15.2
36.4
8.78
127
622
(3013707) Erythrocyte sedimentation rate by Westergren method
1155
8362
3.25
62.46
5.1
3.7
mm/h
10.8
12.3
4.03
1070
7680
(3037467) Urinalysis macro (dipstick) panel - Urine
1026
7555
2.36
43.23
5.0
4.0
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1129
8694
2.59
42.68
7.3
7.2
u/l
75.0
78.4
1.36
1060
8170
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
614
3790
2.11
39.28
3.2
3.0
ng/l
32.1
44.0
0.45
391
2407
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
725
4763
2.09
39.21
5.3
5.4
mmol/l
1.2
1.2
3.50
628
4289
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
513
2983
2.14
38.14
2.2
2.0
u/l
152.8
196.4
0.77
486
2782
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
777
5290
2.06
37.53
5.8
6.3
mmol/l
1.2
1.2
4.41
643
4437
(3019225) pH of Specimen
254
1124
2.54
35.65
3.9
4.0
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
768
5292
2.01
34.87
5.6
5.5
%
55.9
56.8
1.52
712
4955
(40768797) Stomach Pathology biopsy report
305
1481
2.36
34.84
1.3
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1287
10947
3.35
33.75
6.0
4.8
mu/l
1.7
2.3
1.81
1164
10018
(3019069) Monocytes/100 leukocytes in Blood
752
5194
1.97
33.35
6.2
5.8
%
8.3
8.5
0.73
698
4864
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1149
9285
2.37
32.84
4.8
4.1
pmol/l
14.6
14.7
0.42
1036
8454
(3037522) Nuclear Ab [Titer] in Serum
299
1479
2.30
32.50
1.4
1.3
titre
505.8
556.8
0.19
65
321
(3006504) Eosinophils/100 leukocytes in Blood
746
5167
1.96
32.50
5.7
5.6
%
3.0
2.8
1.37
686
4811
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
299
1482
2.30
32.33
4.8
4.3
%
33.1
33.2
0.05
188
987
(3002030) Lymphocytes/100 leukocytes in Blood
766
5368
1.95
32.07
5.9
5.7
%
29.6
28.6
2.22
706
4993
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
703
4812
1.93
31.31
2.5
2.2
nmol/l
80.6
78.5
1.17
613
4346
(3013826) Glucose [Moles/volume] in Serum or Plasma
841
6180
1.91
29.44
4.1
4.1
mmol/l
6.3
6.6
6.12
805
5769
(3022096) Basophils/100 leukocytes in Blood
716
5009
1.88
29.05
5.8
5.6
%
0.7
0.7
2.39
662
4667
(3008898) HLA-B27 [Presence]
105
322
3.45
28.46
1.1
1.0
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
762
5461
1.87
28.43
5.5
5.5
e9/l
0.0
0.0
1.71
678
4722
(42870588) Differential panel, method unspecified - Blood
559
3640
1.90
28.10
5.6
5.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
418
2472
1.99
28.00
1.3
1.2
u/ml
1.9
1.7
0.11
97
639
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1313
11528
3.48
27.96
14.9
11.7
mg/l
17.2
22.8
8.69
1071
8878
(3013115) Eosinophils [#/volume] in Blood
783
5679
1.87
27.92
5.6
5.7
e9/l
0.2
0.2
0.58
700
4972
(3001604) Monocytes [#/volume] in Blood
757
5443
1.86
27.65
5.4
5.5
e9/l
0.6
0.6
0.37
672
4702
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
511
3249
1.91
27.50
2.5
2.4
u/l
55.1
59.7
2.11
457
2999
(3019198) Lymphocytes [#/volume] in Blood
773
5606
1.85
27.34
5.5
5.5
e9/l
1.9
1.9
0.10
701
4938
(3013512) EKG study
503
3209
1.89
26.59
4.1
3.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1338
12017
3.98
24.68
16.2
13.3
mmol/l
139.8
139.8
0.33
1308
11673
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
624
4350
1.79
24.09
2.1
1.9
pmol/l
105.8
97.6
2.68
274
2132
(3023103) Potassium [Moles/volume] in Serum or Plasma
1339
12057
3.96
24.06
16.4
13.5
mmol/l
4.0
3.9
1.17
1305
11683
(3032080) INR in Blood by Coagulation assay
583
4014
1.78
23.24
8.1
7.9
inr
1.2
1.2
0.39
168
1224
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
702
5100
1.76
23.20
4.0
3.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
968
7730
1.83
22.98
3.4
2.8
u/l
41.4
45.2
0.75
880
7208
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
759
5701
1.73
21.73
4.9
6.3
umol/l
9.9
11.1
1.79
716
5419
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
150
653
2.45
21.30
1.4
1.3
au/ml
56.9
36.0
—
5
32
(3036481) Cortisol [Moles/volume] in Serum or Plasma
190
926
2.22
20.77
2.0
2.1
nmol/l
353.1
380.7
0.97
170
857
(40768804) Tissue Pathology biopsy report
679
4993
1.70
20.60
2.2
2.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
368
2297
1.82
19.79
1.6
1.7
mg/l
0.9
1.1
1.75
272
1748
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
416
2710
1.76
19.28
2.5
2.8
ng/l
833.6
1155.2
1.25
338
2283
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1220
10720
2.12
19.06
6.1
5.3
mmol/mol
38.8
39.4
1.71
1098
9883
(3026493) Urate [Moles/volume] in Serum or Plasma
414
2704
1.76
18.96
2.5
2.4
umol/l
1600.4
5266.9
2.44
350
2381
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
157
734
2.28
18.91
2.7
2.3
au/ml
8.6
21.4
—
5
52
(40761511) CBC panel - Blood by Automated count
1337
12249
3.36
18.80
15.3
11.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1258
11203
2.29
18.72
13.6
11.3
ml/min/173m2
81.9
81.3
0.42
1112
9161
(3007164) IgA [Mass/volume] in Serum or Plasma
349
2181
1.80
18.53
1.4
1.4
g/l
2.2
2.3
0.79
180
1340
(3013650) Neutrophils [#/volume] in Blood by Automated count
823
6473
1.66
18.51
6.9
9.1
e9/l
3.9
4.0
0.71
732
5660
(3021960) Folate [Moles/volume] in Serum or Plasma
371
2362
1.78
18.49
1.6
1.5
nmol/l
22.5
21.3
0.74
291
1980
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
396
2590
1.74
17.87
2.4
2.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
226
1244
1.98
17.73
1.3
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
231
1289
1.95
17.40
2.4
2.1
ug/g
125.1
116.4
0.17
166
1021
(36660697) Celiac disease serology panel - Serum
176
903
2.09
16.73
1.2
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
89
338
2.74
16.66
1.8
2.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1272
11485
2.26
16.51
5.2
4.3
mmol/l
5.8
5.8
0.78
1132
10436
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1352
12590
3.63
16.01
11.7
9.6
u/l
25.2
24.8
0.36
1291
12145
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
500
3568
1.63
15.82
3.4
2.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
639
4855
1.58
15.44
3.1
2.6
ug/l
90.8
112.1
3.87
578
4479
(3044640) Blood type and Crossmatch panel - Blood
482
3433
1.62
15.24
2.4
2.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1286
11727
2.28
15.20
5.0
4.2
mmol/l
1.6
1.5
0.30
1161
10798
(3017732) Neutrophils [#/volume] in Blood
154
783
2.09
14.95
2.8
2.7
e9/l
3.9
4.0
0.23
109
625
(3000570) Elastase.pancreatic [Mass/mass] in Stool
75
276
2.82
14.91
1.5
1.4
ug/g
296.8
298.9
0.03
46
154
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1290
11796
2.29
14.84
5.0
4.2
mmol/l
4.9
4.8
0.29
1168
10929
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
86
345
2.59
14.46
2.9
3.7
mmol/l
25.1
25.0
0.14
77
317
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
136
671
2.14
14.27
1.6
1.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
391
2684
1.64
14.16
3.1
2.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1301
11987
2.32
13.85
5.4
4.7
mmol/l
2.8
2.9
0.26
1170
11028
(3015377) Calcium [Moles/volume] in Serum or Plasma
520
3837
1.57
13.83
2.6
3.5
mmol/l
2.4
2.4
0.01
413
3386
(3025941) Bacteria identified in Stool by Culture
122
587
2.18
13.63
1.3
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1248
11335
1.98
13.60
4.4
3.8
mmol/l
1.3
1.3
1.43
1115
10361
(3030467) Casts [#/volume] in Urine by Automated count
393
2740
1.61
13.21
3.2
2.7
e6/l
0.3
0.5
1.58
318
2000
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
884
7378
1.54
13.10
3.1
2.9
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
92
404
2.37
12.76
1.5
1.2
u/ml
1.0
1.0
—
7
21
(3035941) MCH [Entitic mass]
1378
13146
6.16
12.60
22.8
17.7
pg
30.3
30.2
1.06
1359
12945
(3024731) MCV [Entitic volume]
1378
13146
6.16
12.60
22.8
17.7
fl
91.3
91.0
1.62
1359
12946
(3010813) Leukocytes [#/volume] in Blood
1378
13147
6.15
12.58
23.0
17.8
e9/l
6.6
6.6
0.14
1349
12745
(3026361) Erythrocytes [#/volume] in Blood
1378
13148
6.14
12.55
23.0
17.7
e12/l
4.5
4.5
0.02
1351
12756
(3000963) Hemoglobin [Mass/volume] in Blood
1378
13154
6.09
12.41
23.0
17.8
g/l
134.6
134.2
0.68
1361
12955
(3007461) Platelets [#/volume] in Blood
1377
13139
5.77
12.37
23.0
17.7
e9/l
260.4
258.2
0.67
1349
12777
(3024561) Albumin [Mass/volume] in Serum or Plasma
595
4612
1.51
12.19
4.4
4.5
g/l
36.4
35.7
2.52
534
4282
(3019309) Folate [Moles/volume] in Red Blood Cells
274
1788
1.66
11.86
1.8
1.7
nmol/l
1102.8
1141.3
0.27
191
1352
(3009343) pH of Capillary blood
112
553
2.12
11.72
2.8
3.5
ph
7.4
7.4
0.05
15
68
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
108
526
2.14
11.70
2.8
3.5
mmol/l
1.5
2.1
0.92
88
409
(3022313) Gas panel - Capillary blood
90
412
2.27
11.36
2.8
3.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
668
5355
1.48
11.30
5.3
4.6
estimate
0.0
0.0
0.50
174
969
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
112
561
2.08
11.29
2.8
3.5
kpa
5.1
5.2
0.57
103
523
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
96
455
2.19
11.14
2.6
2.1
u/l
37.6
38.8
0.24
91
409
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
36
103
3.56
10.91
2.3
2.2
mg/l
17.8
26.8
0.52
11
26
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
359
2546
1.55
10.89
2.3
2.1
mg/l
2.9
3.0
0.46
310
2158
(3035350) Ketones [Presence] in Urine by Test strip
657
5291
1.46
10.62
3.9
3.3
estimate
0.0
0.0
0.00
172
955
(3009261) Glucose [Presence] in Urine by Test strip
667
5401
1.45
10.39
4.0
3.3
estimate
0.0
0.0
1.32
171
951
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
69
294
2.42
10.27
1.3
1.2
u/ml
22.2
9.3
—
10
51
(3002582) Erythrocytes [#/volume] in Urine
408
3009
1.50
10.21
3.2
2.8
e6/l
47.8
108.8
1.03
332
2244
(3013139) Helicobacter pylori Ag [Presence] in Stool
135
749
1.89
10.17
1.3
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
477
3635
1.48
10.13
3.7
3.3
e6/l
67.3
110.1
1.05
360
2440
(3018418) pH of Serum or Plasma
418
3105
1.49
10.08
4.1
3.9
ph
7.4
7.4
0.13
101
608
(3000494) Fungus identified in Specimen by Culture
203
1288
1.67
9.66
1.4
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
55
221
2.55
9.29
1.5
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
120
661
1.89
9.24
1.8
2.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
92
462
2.06
9.23
1.9
1.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
199
1271
1.66
9.22
5.3
5.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
321
2299
1.52
9.10
1.6
1.6
pmol/l
110931634.5
31601485.4
0.63
247
1905
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
34
107
3.23
8.94
1.4
1.5
%
45.5
63.3
1.29
20
72
(3026008) Bacteria identified in Urine by Culture
433
3306
1.45
8.86
3.2
2.7
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
53
216
2.51
8.71
1.4
1.7
e6/l
5990.2
14781.9
1.57
39
158
(4010399)
127
726
1.82
8.71
1.4
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
189
1217
1.64
8.46
2.3
2.6
umol/l
4.7
7.8
6.07
156
1062
(3007853) Bacteria identified in Skin by Aerobe culture
177
1122
1.66
8.42
1.9
1.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
158
984
1.68
8.03
2.5
2.1
u/l
27.4
44.3
2.60
129
865
(3012516) Albumin [Mass/volume] in Urine
409
3138
1.43
8.01
2.8
3.2
mg/l
269.1
377.6
0.18
203
1871
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
85
438
2.00
7.97
1.7
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
427
3308
1.42
7.90
3.1
3.1
mmol/l
6.9
7.1
0.31
336
2775
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
26
75
3.51
7.84
1.2
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
282
2022
1.50
7.83
2.5
2.3
e6/l
6.8
7.5
0.25
265
1748
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
106
593
1.85
7.80
1.1
1.0
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
183
1194
1.61
7.75
17.2
21.1
inr
1.3
1.3
0.13
24
180
(3002179) Metamyelocytes/100 leukocytes in Blood
135
818
1.72
7.59
4.1
4.0
%
0.4
0.6
0.56
23
177
(3041096) Erythrocytes [Presence] in Urine by Automated
388
2976
1.42
7.53
3.6
3.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
71
350
2.08
7.52
2.0
1.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
133
805
1.72
7.51
4.2
4.2
%
0.0
1.0
0.86
23
188
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
19
45
4.27
7.48
2.8
2.5
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
68
332
2.10
7.39
1.5
1.6
g/l
1.2
1.2
0.47
59
314
(3021788) Differential panel - Synovial fluid
42
166
2.58
7.39
1.3
1.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
143
887
1.68
7.38
4.2
4.2
%
0.4
1.0
2.35
25
244
(3004616) Nuclear Ab [Presence] in Serum
38
143
2.70
7.36
1.2
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
55
247
2.28
7.34
1.2
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
36
132
2.77
7.32
1.5
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
96
532
1.86
7.28
2.6
2.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
138
851
1.69
7.28
4.2
4.2
%
0.0
0.1
5.12
24
225
(3020630) Protein [Mass/volume] in Serum or Plasma
130
789
1.71
7.27
2.0
2.7
g/l
66.5
66.4
0.02
116
722
(3026782) Osmolality of Urine
269
1940
1.48
7.21
2.7
2.4
mosm/kgh2o
511.2
538.1
1.39
244
1655
(3024522) Salmonella sp identified in Specimen by Organism specific culture
36
134
2.73
7.12
1.5
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
36
134
2.73
7.12
1.6
1.6
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
65
317
2.10
7.09
1.5
1.7
g/l
0.2
0.2
0.11
57
301
(3032057) Clostridioides difficile [Presence] in Stool
13
23
5.70
7.07
1.5
2.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
269
1953
1.47
6.95
1.6
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
129
792
1.69
6.92
3.0
3.3
pmol/l
4.4
4.5
0.48
107
699
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
147
934
1.64
6.92
2.1
1.9
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
131
808
1.69
6.91
2.0
2.8
g/l
9.8
10.4
1.56
113
735
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
27
87
3.15
6.88
1.1
1.1
—
34.2
—
0
9
(3044889) 12 lead EKG panel
914
8120
1.37
6.87
3.8
3.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
35
131
2.71
6.86
1.6
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
35
131
2.71
6.86
1.6
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
65
322
2.07
6.82
2.8
2.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
89
492
1.86
6.82
1.2
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
35
132
2.69
6.77
1.6
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
131
814
1.67
6.72
2.1
1.8
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
113
675
1.73
6.70
1.4
1.2
u/ml
233.5
172.4
0.34
106
623
(3012095) Magnesium [Moles/volume] in Serum or Plasma
231
1644
1.49
6.58
2.7
3.6
mmol/l
0.8
0.8
1.55
206
1536
(3022948) Iron [Moles/volume] in Serum or Plasma
220
1551
1.50
6.57
2.4
2.3
umol/l
13.9
13.4
0.45
201
1428
(3021589) Normoblasts [#/volume] in Blood
601
5047
1.34
6.41
9.7
8.6
e9/l
0.0
0.0
0.38
512
4113
(3042936) Bacteria identified in Isolate by Culture
199
1381
1.51
6.40
2.0
1.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
219
1554
1.49
6.32
2.0
1.7
—
—
—
0
0
(3000492) Spirometry study
159
1055
1.57
6.26
1.4
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
77
419
1.89
6.21
1.8
1.9
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
348
2706
1.38
6.05
3.7
3.6
%
96.4
94.1
0.99
338
2640
(3020682) Albumin/Creatinine [Ratio] in Urine
417
3343
1.35
5.97
3.5
3.9
mg/mmol
7.3
7.6
0.06
214
2012
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
31
118
2.66
5.92
1.2
1.3
nmol/l
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
400
3190
1.36
5.92
1.7
1.6
mmol/l
1.4
1.3
0.12
327
2659
(3045424) Erythrocytes [Presence] in Urine
44
199
2.25
5.83
1.6
1.4
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
34
139
2.48
5.64
1.2
1.3
nmol/l
0.5
0.6
0.69
34
133
(4024509)
28
105
2.70
5.52
2.5
1.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
454
3723
1.33
5.49
2.9
3.1
u/l
29.3
31.7
0.53
431
3552
(3037121) Protein [Mass/volume] in Urine
63
339
1.90
5.30
3.8
3.2
g/l
0.3
0.3
0.15
20
134
(3006184) Hemoglobin [Mass/volume] in Capillary blood
44
208
2.15
5.27
2.0
2.1
g/l
127.3
130.7
0.41
33
161
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
26
97
2.71
5.19
1.1
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
18
54
3.36
5.17
1.6
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
18
54
3.36
5.17
1.6
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
68
379
1.84
5.14
1.7
1.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
251
1898
1.39
5.09
4.1
3.2
ng/l
44.7
436.7
4.08
171
1373
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
46
225
2.08
5.06
2.8
2.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
56
295
1.94
5.03
1.5
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
26
99
2.66
5.00
1.2
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
14
36
3.92
4.99
2.1
2.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
31
130
2.42
4.91
1.2
1.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
179
1283
1.45
4.89
5.1
5.5
mmol/l
1.0
1.0
0.50
165
1195
(3023368) Bacteria identified in Blood by Culture
325
2580
1.34
4.83
4.0
4.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
67
381
1.80
4.77
2.4
2.2
nmol/l
10.3
11.7
0.60
54
344
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
57
308
1.89
4.76
1.9
2.0
g/l
39.5
37.4
1.70
45
264
(3014765) Yersinia sp identified in Stool by Organism specific culture
56
301
1.90
4.75
1.1
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
34
153
2.25
4.62
1.5
1.9
g/l
0.5
0.9
1.67
26
113
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
486
4098
1.29
4.62
4.1
3.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
56
305
1.87
4.58
1.1
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
55
298
1.88
4.57
2.0
2.2
ug/l
174.0
455.3
1.08
50
276
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
130
890
1.51
4.47
4.1
3.3
mmol/l
1.2
1.2
0.70
117
767
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
55
301
1.86
4.44
2.8
2.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
51
274
1.89
4.36
1.3
1.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
189
1398
1.41
4.34
2.5
2.3
g/l
2.5
2.4
2.02
170
1297
(3028433) Virus identified in Specimen by Culture
14
40
3.53
4.33
1.5
1.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
99
644
1.58
4.29
1.7
1.9
g/l
1.3
1.5
0.19
82
593
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
178
1309
1.41
4.23
2.6
2.4
%
22.9
23.3
0.14
151
1131
(4062490)
23
90
2.58
4.23
1.3
1.7
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
23
90
2.58
4.23
1.4
1.7
g/l
2.2
2.9
1.71
15
62
(3024139) IgG subclass 3 [Mass/volume] in Serum
23
90
2.58
4.23
1.4
1.7
g/l
0.3
0.4
0.35
15
62
(3027135) IgG subclass 1 [Mass/volume] in Serum
23
90
2.58
4.23
1.4
1.7
g/l
7.1
7.0
0.02
15
61
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
55
307
1.82
4.19
1.2
1.1
u/ml
0.6
4.7
—
5
47
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
9
13
6.96
4.16
2.1
2.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
26
109
2.41
4.16
1.4
1.4
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
38
188
2.05
4.11
1.4
1.4
u/l
29.1
34.0
0.35
28
159
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
164
1195
1.42
4.11
1.6
1.7
%
1.4
1.4
0.04
141
1058
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
61
354
1.76
4.09
2.0
2.1
g/l
9.8
10.2
0.34
49
305
(3025577) Chromium [Mass/volume] in Blood
16
52
3.10
4.09
2.0
2.3
ug/l
2.2
2.7
—
10
41
(3042631) Mycobacterium sp identified in Specimen
28
124
2.28
3.98
2.5
2.2
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
51
283
1.83
3.97
2.5
3.6
mg/l
28.7
67.2
1.07
39
231
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
76
473
1.64
3.96
1.5
1.7
mg/l
2.9
4.2
0.50
58
345
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
50
276
1.84
3.96
2.5
3.6
ratio
1.9
1.2
—
7
23
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
53
300
1.80
3.88
1.2
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
12
34
3.55
3.77
1.1
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
212
1636
1.35
3.76
3.0
2.5
e6/l
1.1
1.2
0.32
127
891
(3029937) Albumin [Presence] in Urine by Test strip
332
2732
1.28
3.70
4.5
3.6
estimate
0.0
0.0
0.88
168
956
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
202
1554
1.35
3.66
3.1
2.6
e6/l
4.9
3.4
0.82
117
812
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
31
149
2.11
3.64
1.3
1.6
nmol/l
44.7
42.9
0.12
26
141
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
50
284
1.79
3.64
2.5
3.6
mg/l
23.0
45.6
1.23
38
236
(3037692) Legionella sp identified in Specimen by Organism specific culture
12
35
3.45
3.62
1.3
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
40
212
1.91
3.61
2.0
2.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
92
614
1.53
3.60
1.3
1.4
iu/l
33.6
34.4
0.08
81
531
(3038515) Glucose [Moles/volume] in Venous blood
5
195
0.25
3.55
5.0
2.5
mmol/l
6.2
7.5
—
5
190
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
29
138
2.12
3.51
1.4
1.3
pmol/l
227.4
297.2
1.27
24
104
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
35
179
1.98
3.50
1.6
1.6
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
17
63
2.72
3.49
1.6
3.4
nmol/l
59.1
120.9
2.40
17
63
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
22
93
2.39
3.49
1.9
1.7
—
—
—
0
0
(3015736) pH of Urine
473
4083
1.24
3.47
3.4
3.0
—
5.8
—
0
6
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
112
787
1.46
3.43
3.3
3.5
ng/l
79.2
81.6
0.12
94
681
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
62
381
1.66
3.43
2.0
2.1
g/l
7.7
7.4
0.85
47
295
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
62
381
1.66
3.43
2.0
2.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
56
335
1.70
3.42
2.1
2.3
g/l
0.6
0.9
0.45
47
289
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
53
314
1.72
3.36
1.9
1.8
u/l
316.9
3856.0
2.36
18
140
(3008037) Lactate [Moles/volume] in Venous blood
6
209
0.28
3.35
4.3
2.5
mmol/l
1.1
1.5
—
6
202
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
85
567
1.53
3.35
1.8
1.5
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
29
141
2.08
3.33
1.0
1.1
u/ml
2.4
1.5
0.33
13
47
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
59
361
1.66
3.33
2.0
2.2
g/l
2.9
3.1
0.89
47
287
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
6
7
8.60
3.26
1.0
1.1
nmol/l
3.5
5.7
—
6
7
(3009542) Hematocrit [Volume Fraction] of Blood
1139
10827
1.29
3.25
15.2
12.9
%
39.8
39.4
0.70
822
7994
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
145
1079
1.38
3.24
3.2
2.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
98
679
1.48
3.24
3.0
2.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
85
572
1.52
3.23
1.3
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
164
1247
1.36
3.21
1.6
1.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
212
1675
1.31
3.20
5.7
4.9
ug/l
1.7
2.6
2.73
189
1470
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
14
49
2.88
3.19
1.4
2.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
14
49
2.88
3.19
1.4
2.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
14
49
2.88
3.19
1.4
2.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
61
381
1.63
3.19
2.0
2.1
g/l
3.7
3.7
0.18
45
279
(40760892) CBC W Ordered Manual Differential panel - Blood
298
2464
1.27
3.16
4.8
4.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
16
61
2.64
3.14
1.4
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
16
61
2.64
3.14
1.4
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
16
61
2.64
3.14
1.4
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
16
61
2.64
3.14
1.4
1.9
—
—
—
0
0
(40758558) Short blood count panel - Blood
340
2858
1.25
3.13
5.4
6.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
140
1043
1.38
3.12
1.5
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
127
931
1.40
3.11
5.3
3.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
34
181
1.90
3.07
1.6
1.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
22
99
2.24
3.07
1.1
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
140
1046
1.38
3.06
2.2
2.1
g/l
0.2
0.2
3.30
132
990
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
45
262
1.74
3.06
1.1
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
16
62
2.60
3.05
1.1
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
26
126
2.08
3.03
1.0
1.1
u/ml
2.5
2.2
0.06
13
46
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
27
133
2.05
3.02
1.6
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
34
182
1.89
3.02
2.3
2.5
%
16.6
16.4
0.07
18
94
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
30
154
1.97
3.01
1.6
1.4
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
19
81
2.36
2.99
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
19
81
2.36
2.99
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
19
81
2.36
2.99
1.2
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
27
134
2.04
2.97
1.3
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
42
243
1.75
2.93
1.6
1.6
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
145
1099
1.36
2.91
3.2
4.6
u/l
220.2
245.7
1.96
131
1047
(3016018) Differential panel - Cerebral spinal fluid
24
115
2.11
2.89
1.3
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
202
1609
1.30
2.88
1.3
1.3
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
6
9
6.69
2.87
1.0
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
32
172
1.88
2.83
1.0
1.1
u/ml
2.9
3.4
0.11
16
79
(3023520) Reticulocytes [#/volume] in Blood
107
775
1.41
2.83
2.9
2.8
e9/l
66.5
72.0
1.06
87
579
(3009214) Lutropin [Units/volume] in Serum or Plasma
38
216
1.78
2.82
1.1
1.3
u/l
13.2
14.4
0.18
27
168
(3010726) Horse dander IgE Ab [Units/volume] in Serum
30
158
1.92
2.81
1.0
1.1
u/ml
1.5
0.9
—
8
35
(3028707) Methadone [Presence] in Urine by Screen method
22
103
2.15
2.81
7.8
2.2
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
27
137
1.99
2.81
1.3
1.2
—
56.5
—
0
5
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
117
863
1.39
2.78
1.3
1.2
iu/ml
260.4
150.9
1.40
46
334
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
33
181
1.84
2.75
1.3
1.3
—
72.0
—
0
5
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
53
333
1.62
2.75
1.3
1.3
miu/ml
238.1
247.2
0.06
25
157
(3002619) Bacteria identified in Specimen by Culture
7
14
5.02
2.73
1.3
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
13
48
2.72
2.72
1.6
1.7
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
19
85
2.25
2.71
1.0
1.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
148
1139
1.34
2.70
1.5
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40
236
1.72
2.63
1.6
1.6
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
13
49
2.67
2.62
1.1
1.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
27
141
1.93
2.61
1.6
1.4
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
18
80
2.27
2.61
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
18
80
2.27
2.61
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
18
80
2.27
2.61
1.2
1.1
—
—
—
0
0
(4094501)
48
299
1.63
2.59
1.2
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
238
1962
1.26
2.58
2.7
3.0
mmol/l
2.4
2.5
0.56
204
1749
(3025549) Creatine [Moles/time] in 24 hour Urine
5
7
7.16
2.55
1.8
1.6
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
35
201
1.76
2.54
1.1
1.1
u/ml
0.1
1.0
2.29
11
75
(3016879) Cocaine [Presence] in Urine
41
247
1.68
2.52
4.7
1.7
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
22
109
2.03
2.47
1.0
1.0
u/ml
0.1
0.3
—
5
26
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
31
174
1.80
2.43
1.6
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
24
124
1.95
2.41
1.2
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
29
160
1.83
2.40
1.2
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
28
153
1.85
2.39
1.5
1.4
—
—
—
0
0
(4146454)
21
104
2.03
2.37
3.1
3.0
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
24
125
1.94
2.36
1.5
1.2
u/l
51.1
55.9
0.32
15
83
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
32
184
1.76
2.33
1.3
1.2
u/ml
429.0
282.3
0.48
21
107
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
47
300
1.59
2.32
2.0
2.1
g/l
0.0
0.0
0.00
42
273
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
17
78
2.19
2.31
1.1
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
31
177
1.77
2.31
8.0
2.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
43
269
1.62
2.31
4.6
1.6
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
9
28
3.23
2.31
1.1
2.9
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
26
141
1.86
2.28
1.2
1.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
29
163
1.80
2.28
1.0
1.1
u/ml
1.6
2.0
0.12
12
67
(3027008) Opiates [Presence] in Urine
43
270
1.61
2.28
4.6
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
35
209
1.69
2.25
4.6
3.3
%
57.3
57.3
0.01
35
209
(1761482) Bacteria [#/volume] in Urine by Culture
12
271
0.44
2.24
4.8
4.0
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
44
280
1.59
2.22
2.0
2.1
g/l
0.0
0.0
0.00
39
255
(40760888) Immunoglobulin light chains.free panel - Serum
36
218
1.67
2.20
1.9
4.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
43
273
1.59
2.19
4.6
1.6
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
8
24
3.35
2.18
1.0
1.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
79
571
1.41
2.17
4.2
5.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
21
108
1.96
2.16
1.5
1.5
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
13
55
2.38
2.12
1.2
1.1
u/l
1.6
1.2
—
7
32
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
29
168
1.74
2.08
1.0
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
21
110
1.92
2.06
2.0
1.7
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
13
56
2.33
2.05
1.1
1.5
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
43
278
1.56
2.05
2.0
2.1
g/l
0.0
0.0
0.00
38
254
(3044290) Cell count panel - Cerebral spinal fluid
35
215
1.64
2.04
1.3
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
28
162
1.74
2.03
1.1
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
17
83
2.06
2.01
1.4
1.5
%
21.6
32.7
—
7
53
(3034891) Synovial lining cells/100 cells in Synovial fluid
11
44
2.51
2.01
1.4
1.3
%
—
2.0
—
0
11
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
11
44
2.51
2.01
1.1
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
11
44
2.51
2.01
1.1
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
9
32
2.82
2.00
1.1
1.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
21
3.34
1.96
1.1
1.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
17
84
2.04
1.96
1.4
1.4
e6/l
24078.4
48415.0
0.26
11
59
(3011397) Hemoglobin [Presence] in Urine by Test strip
276
2379
1.20
1.95
3.8
3.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
32
195
1.66
1.94
3.6
3.0
mmol/l
3.8
2.6
1.08
21
132
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
10
39
2.58
1.92
1.2
1.8
—
3900.0
—
0
6
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
20
106
1.90
1.91
1.5
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
32
196
1.65
1.91
5.8
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
18
92
1.97
1.90
1.6
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
18
92
1.97
1.90
1.6
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
18
92
1.97
1.90
1.6
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
23
128
1.81
1.90
1.7
1.4
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
33
204
1.63
1.90
1.3
1.3
—
21.4
—
0
5
(3025018) Bordetella pertussis Ab [Titer] in Serum
14
65
2.17
1.88
1.3
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
18
93
1.95
1.85
1.7
7.4
mmol/l
7.8
7.1
0.41
12
79
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
73
537
1.38
1.85
1.9
1.7
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
13
59
2.21
1.84
1.1
1.5
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
5
12
4.18
1.82
2.8
4.0
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
16
80
2.01
1.80
1.9
1.3
u/ml
1.3
1.0
—
10
30
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
16
80
2.01
1.80
1.6
1.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
9
35
2.58
1.80
1.3
9.5
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
8
29
2.77
1.79
1.1
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
32
200
1.61
1.78
1.3
1.2
—
—
—
0
0
(4027681)
13
60
2.18
1.78
1.2
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
18
3.34
1.74
1.2
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
282
2460
1.18
1.74
1.5
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
131
1058
1.26
1.73
2.0
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
131
1060
1.26
1.71
2.4
2.7
%
1.7
1.8
0.77
105
949
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
130
1051
1.26
1.71
5.8
7.4
kpa
5.1
5.1
0.13
125
1014
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
15
75
2.01
1.70
1.4
1.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
10
42
2.39
1.68
2.1
1.3
—
—
—
0
0
(3012565) Volume of 24 hour Urine
12
55
2.19
1.67
2.0
2.7
ml
1708.3
1828.7
0.21
12
47
(3020961) Endomysium IgA Ab [Titer] in Serum
69
514
1.36
1.64
1.1
1.1
—
106.9
—
0
16
(3002385) Erythrocyte distribution width [Ratio]
1018
9769
1.16
1.64
17.1
14.8
%
13.6
13.7
0.91
1011
9534
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
31
197
1.59
1.63
1.4
1.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
14
70
2.01
1.59
1.0
1.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
70
526
1.35
1.59
1.4
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
199
1699
1.20
1.57
1.7
1.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
42
289
1.47
1.56
1.3
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
35
232
1.52
1.55
1.6
1.6
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
34
224
1.53
1.55
1.6
1.5
e6/l
84.1
579.2
0.84
28
180
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
34
224
1.53
1.55
1.5
1.5
e6/l
26.1
12.0
0.43
27
169
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
57
416
1.39
1.55
1.7
1.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
36
242
1.50
1.50
2.6
2.4
ug/min
56.3
79.9
0.28
20
145
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
11
51
2.17
1.50
1.1
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
18
101
1.79
1.49
2.1
1.8
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
13
65
2.01
1.49
1.0
1.6
—
25.4
—
0
8
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
45
318
1.43
1.47
1.7
1.6
iu/ml
0.2
0.6
—
6
56
(3008757) Leukocyte morphology finding [Identifier] in Blood
18
102
1.77
1.45
3.1
3.9
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
11
52
2.12
1.44
1.0
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
5
16
3.13
1.44
1.0
1.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
43
303
1.43
1.44
1.7
3.4
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
56
417
1.36
1.37
3.2
3.4
mmol/l
24.3
24.1
0.19
51
381
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
9
41
2.20
1.37
1.2
1.0
miu/ml
1610.0
1708.8
—
9
41
(3024891) Influenza virus A+B Ag [Presence] in Specimen
39
273
1.44
1.36
1.2
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
127
1054
1.23
1.36
5.9
7.4
mmol/l
1.2
1.2
0.07
101
847
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
28
183
1.54
1.35
1.3
1.3
u/ml
168.2
107.3
—
6
37
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
39
0.00
1.34
0.0
1.9
—
—
—
0
0
(4015189)
5
18
2.78
1.28
5.8
2.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
30
202
1.50
1.28
1.3
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
62
1.94
1.28
1.3
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
8
35
2.29
1.27
1.1
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
38
269
1.42
1.26
1.2
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
26
170
1.54
1.26
3.9
3.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
18
107
1.69
1.26
1.3
1.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
94
763
1.25
1.25
2.8
2.8
ng/l
95.7
185.1
5.11
88
675
(3010375) cycloSPORINE [Mass/volume] in Blood
9
45
2.01
1.23
32.7
28.8
ug/l
93.3
117.3
—
9
36
(21494755) Public health laboratory ask at order entry panel
96
1169
0.81
1.23
1.2
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
12
63
1.91
1.23
1.3
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
28
188
1.50
1.22
2.5
2.6
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
19
2.64
1.21
3.6
1.4
ng/l
112.7
84.1
—
5
19
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
26
172
1.52
1.21
1.2
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
118
986
1.21
1.20
3.6
3.0
ug/l
0.7
0.8
0.47
78
661
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
26
2.31
1.18
1.0
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
8
38
2.11
1.18
2.5
2.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
64
1.88
1.18
1.3
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
18
110
1.64
1.15
1.3
1.8
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
7
30
2.34
1.12
1.3
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
27
184
1.48
1.11
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
27
184
1.48
1.11
1.3
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
125
1060
1.20
1.11
2.1
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
36
260
1.39
1.10
1.8
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
17
104
1.64
1.09
4.6
2.8
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
7
32
2.19
1.08
1.0
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
167
1457
1.17
1.07
1.5
1.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
16
98
1.64
1.03
1.6
1.7
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
16
98
1.64
1.03
1.0
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
8
151
0.53
1.03
1.1
1.2
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
11
60
1.84
1.03
1.2
1.3
—
72.2
—
0
9
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
34
2.06
1.03
1.0
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
34
2.06
1.03
2.1
2.9
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
19
122
1.57
1.02
2.1
2.3
pg
33.1
32.4
0.33
19
122
(3034426) Prothrombin time (PT)
7
35
2.00
1.00
1.3
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
13
76
1.72
0.99
1.0
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
11
61
1.81
0.98
1.5
1.6
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
36
1.95
0.97
2.3
2.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
18
116
1.56
0.96
1.1
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
10
54
1.86
0.96
1.6
1.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
12
69
1.75
0.96
1.1
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
26
182
1.44
0.96
1.3
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
23
157
1.47
0.96
2.3
3.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
88
735
1.21
0.94
2.5
2.2
ug/l
3.5
7.0
4.93
61
642
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
62
1.78
0.94
1.1
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
15
93
1.62
0.94
1.0
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
10
55
1.82
0.92
1.6
1.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
10
55
1.82
0.92
1.4
2.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
43
331
1.31
0.91
1.3
1.2
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
51
402
1.28
0.91
1.5
1.9
g/l
1.6
1.6
0.01
46
348
(40761535) Cells panel - Urine sediment
90
757
1.20
0.91
3.8
3.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
17
110
1.55
0.90
1.2
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
15
231
0.65
0.90
1.2
1.6
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
43
332
1.30
0.90
1.9
2.0
iu/l
3.2
5.0
1.24
15
123
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
63
1.75
0.90
1.1
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
6
29
2.07
0.89
1.0
2.5
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
10
56
1.79
0.88
1.2
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
24
169
1.43
0.87
1.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
6
30
2.00
0.87
1.2
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
6
30
2.00
0.87
1.2
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
6
30
2.00
0.87
1.2
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
6
30
2.00
0.87
1.2
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
6
31
1.94
0.84
2.2
1.5
—
—
—
0
0
(4281824)
10
166
0.60
0.83
1.2
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
19
129
1.48
0.83
1.2
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
24
171
1.41
0.83
1.2
1.2
u/ml
1.2
3.2
0.94
11
56
(3047181) Lactate [Moles/volume] in Blood
37
284
1.31
0.82
3.6
7.8
mmol/l
1.1
1.3
1.03
32
248
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
32
1.88
0.82
1.3
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
6
32
1.88
0.82
1.3
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
8
47
1.71
0.80
1.1
1.2
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
170
1521
1.13
0.80
1.7
2.1
s
29.3
29.5
0.15
165
1476
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
0
25
0.00
0.79
0.0
1.3
—
19.8
—
0
20
(3038177) Helicobacter pylori Ab [Presence] in Serum
27
199
1.36
0.78
1.4
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
122
0.57
0.78
1.1
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
151
1348
1.13
0.75
4.6
4.1
%
24.1
21.2
0.67
72
659
(4133840)
5
24
2.09
0.74
1.6
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
9
54
1.67
0.74
2.0
1.3
nmol/l
140.8
130.2
—
9
54
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
25
2.00
0.72
1.2
1.4
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
5
25
2.00
0.72
5.8
4.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
25
2.00
0.72
1.0
1.8
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
7
42
1.67
0.68
1.1
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
236
2176
1.10
0.68
4.1
3.6
kg/l
1.0
1.0
0.42
42
344
(3016650) Hepatitis A virus Ab [Presence] in Serum
23
170
1.36
0.67
1.0
1.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
59
494
1.20
0.67
6.5
10.5
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
29
1.73
0.64
2.4
1.5
ug/l
11.1
8.7
—
5
29
(3017569) Oxygen content in Arterial blood
8
49
1.64
0.62
1.5
3.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
10
63
1.59
0.62
5.9
2.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
27
209
1.30
0.60
1.6
1.7
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
23
298
0.77
0.58
2.8
3.5
u/ml
23.3
31.6
0.35
23
291
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
16
219
0.73
0.58
1.4
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
6
35
1.72
0.57
1.2
1.1
—
—
—
0
0
(4268621)
16
115
1.40
0.56
2.5
2.3
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
5
88
0.57
0.56
1.2
1.4
—
1.5
—
0
8
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
37
1.62
0.55
1.0
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
23
177
1.30
0.55
1.2
1.2
u/ml
3.1
3.3
0.08
11
66
(3000991) Gas panel - Venous blood
85
751
1.14
0.53
7.2
7.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
89
791
1.13
0.52
1.8
1.5
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
99
0.60
0.52
2.2
1.5
g/l
0.8
1.0
—
6
99
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
14
100
1.40
0.52
1.1
1.3
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
19
144
1.32
0.50
1.2
1.3
mmol/l
7.1
7.4
0.19
13
100
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
168
0.71
0.50
1.5
1.6
—
—
—
0
0
(1002224) Polysomnography panel
59
510
1.16
0.50
1.1
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
13
179
0.72
0.50
1.5
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
67
1.50
0.49
1.6
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
10
143
0.70
0.47
1.7
1.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
31
376
0.82
0.47
1.5
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
24
299
0.80
0.47
1.1
1.3
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
26
209
1.25
0.46
7.1
4.9
iu/ml
24383.7
180.1
—
6
18
(3050129) First trimester maternal screen panel - Serum or Plasma
20
254
0.78
0.46
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
17
220
0.77
0.45
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
17
220
0.77
0.45
1.5
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
14
186
0.75
0.44
1.6
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
17
219
0.77
0.44
1.5
1.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
73
817
0.89
0.43
3.7
3.2
mmol/l
1.3
1.9
0.58
65
664
(3037556) Urate [Mass/volume] in Serum or Plasma
5
31
1.62
0.43
1.4
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
31
1.62
0.43
1.6
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
11
151
0.73
0.43
1.0
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
64
566
1.14
0.42
1.3
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
129
1188
1.09
0.42
3.5
4.5
ug/l
6.1
19.7
1.47
103
936
(4198724)
5
32
1.56
0.42
1.2
1.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
32
1.56
0.42
1.6
1.1
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
8
57
1.41
0.42
1.0
1.0
—
0.3
—
0
12
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
33
1.52
0.41
3.8
3.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
15
0.00
0.41
0.0
7.6
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
16
0.00
0.41
0.0
2.3
—
1.2
—
0
16
(3015183) Erythrocyte sedimentation rate
8
59
1.36
0.41
1.4
1.1
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
17
0.00
0.40
0.0
3.2
—
6.0
—
0
10
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
14
183
0.76
0.40
1.7
1.8
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
34
1.47
0.40
1.8
1.6
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
21
168
1.25
0.40
1.3
1.1
u/ml
0.8
3.5
—
7
88
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
12
88
1.37
0.40
4.7
3.4
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
12
88
1.37
0.40
1.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
13
171
0.76
0.39
1.5
1.5
—
—
—
0
0
(3036489) Thrombin time
35
410
0.85
0.39
1.5
1.9
s
25.2
21.3
0.47
28
354
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
2.6
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
19
0.00
0.39
0.0
6.7
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
36
1.39
0.38
1.0
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
9
67
1.35
0.38
3.9
1.5
%
11.2
10.7
—
9
67
(40768446) Kidney Pathology biopsy report
5
37
1.35
0.37
1.8
1.5
—
—
—
0
0
(3004451) EKG impression Narrative
5
37
1.35
0.37
1.2
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
19
235
0.81
0.37
1.6
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
33
281
1.18
0.36
4.2
3.0
u/ml
0.4
0.4
0.18
18
161
(4035726)
127
1181
1.08
0.35
1.3
1.4
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
6
43
1.40
0.35
1.2
1.5
nmol/l
1.1
2.9
—
6
34
(3005033) Fetal Nuchal fold Thickness US
14
178
0.78
0.34
1.6
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
32
372
0.86
0.34
1.5
1.9
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
11
144
0.76
0.33
1.4
1.4
—
—
—
0
0
(4306422)
20
164
1.22
0.32
1.3
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
7
96
0.73
0.31
1.1
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
7
97
0.72
0.31
1.1
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
14
111
1.26
0.30
1.1
1.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
22
185
1.19
0.29
1.2
1.5
nmol/l
0.5
0.4
0.16
11
130
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
17
206
0.82
0.29
1.1
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
17
139
1.23
0.29
1.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
8
64
1.25
0.27
1.1
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
12
95
1.27
0.26
1.7
2.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
107
1138
0.94
0.25
1.8
1.8
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
15
123
1.22
0.25
1.2
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
54
493
1.10
0.25
1.3
1.5
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
9
77
1.17
0.24
1.0
1.3
—
67.1
—
0
7
(3018405) Lactate [Moles/volume] in Arterial blood
34
304
1.12
0.22
5.8
3.5
mmol/l
1.4
1.3
0.17
34
299
(3006462) Nitrate [Presence] in Urine
5
41
1.22
0.22
3.6
3.0
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
39
353
1.11
0.21
2.5
2.2
ug/l
0.9
2.2
0.78
32
321
(3024263) Appearance of Synovial fluid
5
42
1.19
0.21
1.8
2.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.1
—
6.2
—
0
5
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
2.2
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.2
—
13.6
—
0
10
(3000285) Sodium [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
25
220
1.14
0.21
1.4
2.1
nmol/l
0.9
0.8
0.07
20
177
(40768441) Liver Pathology biopsy report
8
101
0.79
0.21
1.4
1.3
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
24
211
1.14
0.20
1.4
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
19
165
1.15
0.19
1.1
1.1
—
—
—
0
0
(3020891) Body temperature
37
337
1.10
0.19
7.0
3.7
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
37
404
0.91
0.18
3.6
2.1
%
1.6
1.2
0.48
37
399
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
62
1.13
0.17
2.0
1.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
11
92
1.20
0.16
2.0
2.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
9
79
1.14
0.15
1.1
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
9
81
1.11
0.15
12.6
6.6
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
11
94
1.17
0.13
1.4
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
75
779
0.96
0.10
1.7
1.7
—
—
—
0
0
(4211845)
5
45
1.11
0.09
3.6
2.9
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
80
828
0.96
0.09
3.0
2.4
ml/min/173m2
69.1
65.6
0.32
35
321
(3051387) C reactive protein [Mass/volume] in Capillary blood
27
252
1.07
0.09
5.3
3.7
mg/l
37.0
22.4
—
9
151
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
75
776
0.96
0.09
1.4
1.5
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
33
349
0.94
0.08
1.3
2.1
%
98.7
89.6
1.22
26
321
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
10
113
0.88
0.08
1.1
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
67
1.05
0.08
1.0
1.1
—
—
—
0
0
(44813793)
7
67
1.05
0.08
1.1
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
72
0.83
0.07
1.2
1.6
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
74
0.81
0.07
1.2
1.8
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
13
118
1.10
0.07
1.6
3.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
41
393
1.04
0.07
3.5
4.1
u/ml
20.3
937.0
1.36
35
339
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
11
120
0.92
0.05
2.1
2.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
77
759
1.02
0.02
1.4
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
454
4527
1.00
0.01
2.6
2.7
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
14
136
1.03
0.00
1.6
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
51
514
0.99
0.00
2.5
3.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
20
202
0.99
0.00
1.9
1.8
—
—
—
0
0
(4034850)
36
358
1.01
0.00
7.4
7.6
—
—
—
0
0
(44790047)
11
109
1.01
0.00
2.2
1.5
—
—
—
0
0
(44806118)
11
109
1.01
0.00
2.2
1.5
—
—
—
0
0
(44790048)
11
109
1.01
0.00
2.2
1.5
—
—
—
0
0
(44790049)
11
109
1.01
0.00
2.2
1.5
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
12
121
0.99
0.00
9.6
4.8
u/ml
70.7
98.3
—
5
33
(3003694) ABO and Rh group [Type] in Blood
312
3118
1.00
0.00
1.5
1.4
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
14
143
0.98
0.00
2.1
2.1
u/ml
2.5
32.0
0.56
14
138
(40768793) Breast Pathology biopsy report
40
403
0.99
0.00
1.3
1.3
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.4
—
0.1
—
0
5
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
1.4
—
0
5
(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
2.3
—
0
5
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
19.3
—
0
5
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
5.2
—
370.2
—
0
5
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
60
1.00
0.00
1.3
2.9
u/ml
599.7
1625.8
—
6
60
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
1.0
—
38.1
—
0
8
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
19
190
1.00
0.00
1.2
1.1
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
6
62
0.97
0.00
1.0
1.1
—
4.0
—
0
7
(40760409) HLA-A [Type] by High resolution
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
9
0.00
0.00
0.0
3.6
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4212803)
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
5
51
0.98
0.00
1.2
1.7
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
0
6
0.00
0.00
0.0
1.5
—
28.1
—
0
6
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
9
91
0.99
0.00
2.2
1.5
umol/l
10.3
11.4
—
9
86
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
5
53
0.94
0.00
1.2
5.4
—
38.8
—
0
10
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
190.7
—
0
6
(3011544) Albumin [Mass/volume] in Pleural fluid
0
9
0.00
0.00
0.0
1.0
—
19.3
—
0
9
(3025315) Body weight
0
7
0.00
0.00
0.0
4.3
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
1.0
—
7.9
—
0
8
(3013862) HLA-DP [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
5
57
0.88
0.00
1.8
3.1
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
7
72
0.97
0.00
1.7
2.2
—
—
—
0
0
(3013762) Body weight Measured
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
19
190
1.00
0.00
1.2
1.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
9
0.00
0.00
0.0
7.1
—
—
—
0
0
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
1.0
—
21.7
—
0
8
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
7.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint M13_GLUTEALTEND and mortality.

Females

Parameter HR [95% CI] p-value
M13_GLUTEALTEND 0.849 [0.71, 1.02] 0.083
Birth year 0.998 [0.99, 1.01] 0.645

During the follow-up period (1.1.1998 — 31.12.2019), 203 out of 3143 females with M13_GLUTEALTEND died.

Males

Parameter HR [95% CI] p-value
M13_GLUTEALTEND 0.776 [0.6, 1.01] 0.058
Birth year 0.985 [0.98, 0.99] 0.002

During the follow-up period (1.1.1998 — 31.12.2019), 78 out of 992 males with M13_GLUTEALTEND died.

Mortality risk

Mortality risk for people of age

years, who have M13_GLUTEALTEND.

N-year risk Females Males
1 0.103% 0.125%
5 0.46% 0.885%
10 1.432% 2.112%
15 2.617% 3.874%
20 4.495% 6.693%

Relationships between endpoints

Index endpoint: M13_GLUTEALTEND – Gluteal tendinitis

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data